InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-24.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by FRIEDMAN CATHY, Director. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. Cumulatively, 9 disclosures have been recorded. History available since 14 December 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
23,443 shares0Class A Common StockSEC:0001209191-23-038186:0
26,800 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-22-028642:0
9,945 shares0Class A Common StockSEC:0001209191-22-038080:0
5,500 shares0Common StockSEC:0001209191-22-004785:0
5,500 shares0Common StockSEC:0001209191-22-004785
3,765,842 shares0Common StockSEC:0001209191-21-069485
3,765,842 shares0Common StockSEC:0001209191-21-069485:0
3,765,842 sharesCommon StockSEC:0001209191-21-042795:0
3,765,842 sharesCommon StockSEC:0001209191-21-042795
9 of 9 declarations
About FRIEDMAN CATHY
Cathy Friedman is a Board Member at Lyell Immunopharma, Inc., Radius Health, Inc., and Seer, Inc. She plays a key role in the governance of these companies, participating in strategic decision-making and guiding operations. Her experience in the biopharmaceutical sector is an asset to the boards, allowing these companies to focus on innovation and growth.
